Chronic Hepatitis B Patients With Concurrent MAFLD: Cohort Study and Exercise Intervention.
Sponsored by National Taiwan University Hospital
About this trial
Last updated 3 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Trial Timing
Started 3 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
* Age >18 years of age
* Either gender
* HBV treatment naïve
* Capable of taking exercise
* HBsAg positivity for >6 months
* Evidence of fatty liver in both abdominal ultrasonography and Fibroscan™(CAP>215)
Exclusion Criteria
* Age >70 years of age
* Evidence of liver cirrhosis
* Patients fulfilling reimbursement criteria for HBV treatment
* Evidence of severe cardiopulmonary diseases
* Evidence of serious hip or knee problems, incapable of taking exercise
* Evidence of liver decompensation
* Evidence of active HCV (positive for serum HCV RNA) or HIV infection (positive for anti-HCV)
* Clinical diagnosis of Alzheimer's Disease
* Thyroid disease
